Free Trial
NASDAQ:RKDA

Arcadia Biosciences (RKDA) Stock Price, News & Analysis

Arcadia Biosciences logo
$1.06 0.00 (0.00%)
As of 03:56 PM Eastern

About Arcadia Biosciences Stock (NASDAQ:RKDA)

Advanced

Key Stats

Today's Range
$1.05
$1.10
50-Day Range
$1.05
$2.16
52-Week Range
$0.89
$6.71
Volume
29,205 shs
Average Volume
33,129 shs
Market Capitalization
$2.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Arcadia Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

RKDA MarketRank™: 

Arcadia Biosciences scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Arcadia Biosciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Arcadia Biosciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about Arcadia Biosciences' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Arcadia Biosciences is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Arcadia Biosciences is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Arcadia Biosciences has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.34% of the float of Arcadia Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Arcadia Biosciences has a short interest ratio ("days to cover") of 0.16, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Arcadia Biosciences has recently increased by 297.43%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Arcadia Biosciences does not currently pay a dividend.

  • Dividend Growth

    Arcadia Biosciences does not have a long track record of dividend growth.

  • News Sentiment

    Arcadia Biosciences has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Arcadia Biosciences this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Arcadia Biosciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Arcadia Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    8.20% of the stock of Arcadia Biosciences is held by insiders.

  • Percentage Held by Institutions

    17.73% of the stock of Arcadia Biosciences is held by institutions.

  • Read more about Arcadia Biosciences' insider trading history.
Receive RKDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arcadia Biosciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RKDA Stock News Headlines

Nobody Understands Why Trump Is Invading Iran (here’s the answer)
Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.tc pixel
See More Headlines

RKDA Stock Analysis - Frequently Asked Questions

Arcadia Biosciences' stock was trading at $1.98 at the start of the year. Since then, RKDA stock has decreased by 46.5% and is now trading at $1.06.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) announced its quarterly earnings results on Thursday, March, 26th. The basic materials company reported ($0.98) EPS for the quarter, missing the consensus estimate of ($0.66) by $0.32. The basic materials company earned $0.90 million during the quarter, compared to analysts' expectations of $1.40 million. Arcadia Biosciences had a negative net margin of 48.15% and a positive trailing twelve-month return on equity of 37.36%.

Arcadia Biosciences's stock reverse split on Wednesday, January 24th 2018.The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 23rd 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Arcadia Biosciences (RKDA) raised $66 million in an IPO on Friday, May 15th 2015. The company issued 8,200,000 shares at a price of $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray served as the underwriters for the IPO.

Shares of RKDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arcadia Biosciences investors own include NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), GE Aerospace (GE), Arista Networks (ANET), Advanced Micro Devices (AMD) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
3/26/2026
Today
5/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Agriculture
Current Symbol
NASDAQ:RKDA
CIK
1469443
Employees
60
Year Founded
2002

Profitability

EPS (Trailing Twelve Months)
($1.72)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.34 million
Net Margins
-48.15%
Pretax Margin
-47.98%
Return on Equity
37.36%
Return on Assets
23.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.09
Quick Ratio
2.50

Sales & Book Value

Annual Sales
$4.86 million
Price / Sales
0.45
Cash Flow
$1.29 per share
Price / Cash Flow
0.82
Book Value
$2.39 per share
Price / Book
0.44

Miscellaneous

Outstanding Shares
2,060,000
Free Float
1,888,000
Market Cap
$2.18 million
Optionable
Not Optionable
Beta
0.52

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:RKDA) was last updated on 5/13/2026 by MarketBeat.com Staff.
From Our Partners